SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

ABBASI SAMI S

(Last)

(First)

(Middle)

3600 JP MORGAN CHASE TOWER

2200 ROSS AVE.

(Street)

DALLAS

75201-2776

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
RADIOLOGIX INC [ RGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
04/26/2006

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $.0001	12/03/2004		A		300,000⁽¹⁾	A	$0	300,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$3.15							07/21/2001⁽²⁾	06/20/2011	Common Stock, par value $.0001	25,000		25,000	D
Employee Stock Option (Right to Buy)	$4.88							07/13/2001⁽³⁾	12/12/2010	Common Stock, par value $.0001	175,000		200,000	D
Employee Stock Option (Right to Buy)	$11.19							03/11/2002⁽²⁾	02/10/2012	Common Stock, par value $.0001	75,000		275,000	D
Employee Stock Option (Right to Buy)	$2.6							05/09/2003⁽⁴⁾	05/08/2013	Common Stock, par value $.0001	250,000		525,000	D
Employee Stock Option (Right to Buy)	$3.79							11/24/2004⁽⁵⁾	11/23/2014	Common Stock, par value $.0001	500,000		1,025,000	D
Employee Stock Option (Right to Buy)	$1.7	04/26/2006		A		100,000		04/26/2007⁽⁶⁾	04/25/2016	Common Stock, par value $.0001	100,000	$0	1,125,000	D

Explanation of Responses:

1. The shares included in table are restricted shares, subject to forfeiture, that were awarded to Mr. Abbasi pursuant to the Radiologix, Inc. 2004 Long-Term Incentive Compensation Plan. If Mr. Abbasi remains employed by Radiologix during the vesting period of the award, then the restrictions will expire as to 100,000 of the restricted shares on each of November 24, 2005, 2006, and 2007.

2. The option vests in equal successive monthly installments over a 60-month period at a rate of 1/60th of the grant total per month starting one month after the grant date.

3. The option became exercisable for 7/60ths of the grant total on the grant date. The option also vests in equal successive monthly installments over a 53-month period at a rate of 1/60th of grant total per month beginning one month after the grant date.

4. The option becomes exercisable for 75,000 shares on May 9, 2003, and for 25,000 additional shares on each of May 9, 2004, and May 9, 2005. The option becomes exercisable for the following portions of the remaining 125,000 option shares if and when for 20 consecutive trading days the closing sales price of the registrant's common stock is greater than the following target prices: 25,000 shares for a price greater than $5.00; 25,000 shares for a price greater than $7.50; 25,000 shares for a price greater than $10.00; 25,000 shares for a price greater than $12.50; and 25,000 shares for a price greater than $15.00.

5. The option became exercisable for 150,000 of the grant total on the date the Board of Directors determined to make the grant. As to the remaining 350,000 shares, the option vests in equal successive monthly installments of 7,291 shares for 48 months following the Board determination date, and in equal annual installments of 8 shares on each of November 30, 2005, 2006, 2007, and 2008.

6. The option becomes exercisable for 20,000 share of the grant total on the first anniversary of the grant date. As to the remaining 80,000 shares, the option vests in equal successive monthly installments of 1,667 shares for 47 months following the first anniversary of the grant date. On the 48th month following the first anniversary of the grant date, the final 1,651 options shall vest.

	/s/ Sami S. Abbasi	04/28/2006
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.